JPRN-UMIN000009769已完成2 期
Pharmacokinetic study of busulfan in allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies using once daily intravenous busulfan and fludarabine as conditioning regimen - IVBU1002(FB4)-PK: Pharmacokinetic study of busulfan in once daily intravenous busulfan and fludarabine phosphate
Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital0 个研究点目标入组 30 人开始时间: 2013年1月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients who withdraw the consent to participate in this study (2) Patients who are considered as inappropriate to register by attending physicians
研究者
相似试验
已完成
2 期
Pharmacokinetic study of busulfan in allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies using once daily intravenous busulfan and cyclophosphamide as conditioning regimeacute myeloid leukemia(AML) myelodysplastic syndrome(MDS) chronic myelogenous leukemia(CML)JPRN-UMIN000009767Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital30
已完成
不适用
Pharmacokinetic studies of Busulfan as part of conditioning therapy prior to allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisD47.1Chronic myeloproliferative diseaseMyelofibrosisDRKS00015217niversitätsklinikum Hamburg-Eppendorf37
已完成
不适用
Pharmacokinetic study of intravenous busulfan in allogeneic hematopoietic stem cell transplantation for patients using intravenous busulfan and cyclophosphamide or fludarabine as conditioning regimens.Acute myeloid leukemia (AML),Acute lymphoblastic leukemia (ALL),Myelodysplastic syndrome (MDS), Chronic myeloid leukemia (CML)JPRN-UMIN000018693Kanto Study Group for Cell Therapy40
进行中（未招募）
1 期
Determine the efficacy and tolerability of appropriate doses of busulfan to administer in patients with high risk of hematological disease.hematological malignancies : Acute Myeloblastic Leukemia, Chronic Lymphoïd Leukemia, Multiple myéloma, Acute lymphoblastic leukemia.MedDRA version: 17.0Level: LLTClassification code 10063625Term: Acute lymphoblastic leukemia recurrentSystem Organ Class: 100000004864MedDRA version: 17.0Level: LLTClassification code 10000878Term: Acute myeloblastic leukemiaSystem Organ Class: 100000004864EUCTR2014-000758-12-FRINSTITUT PAOLI CALMETTES33
Unknown
2 期
Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute LeukemiaAcute LeukemiaNCT01498016Shanghai Jiao Tong University School of Medicine60